A study published in 2007 showed that RA patients who failed to respond to TNFi were found to have significantly higher IgA-RF levels than responders, and in multivariate analysis IgA-RF was the only autoantibody independently predicting a blunted response [71]. This evidence concerns the gene CD79A and rheumatoid arthritis.